LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.28 | 27.76 | 1340 | 838 | 1.5977 | 1.2000 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.28 | 27.76 | 8 | 838 | 0.0095 | -0.2235 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 17.28 | 27.76 | 1295 | 838 | 1.5440 | 1.1847 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.98 | 27.76 | 234 | 941 | 0.2486 | 0.5210 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.98 | 27.76 | 1345 | 941 | 1.4291 | 1.1455 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.98 | 27.76 | 10 | 941 | 0.0106 | -0.1820 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.98 | 27.76 | 1371 | 941 | 1.4567 | 1.1536 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 20.68 | 27.76 | 553 | 1119 | 0.4942 | 0.7524 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 20.68 | 27.76 | 1362 | 1119 | 1.2172 | 1.0751 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 20.68 | 27.76 | 16 | 1119 | 0.0143 | -0.0982 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 20.68 | 27.76 | 1341 | 1119 | 1.1984 | 1.0690 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 22.39 | 27.76 | 1027 | 1305 | 0.7865 | 0.9154 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 22.39 | 27.76 | 1355 | 1305 | 1.0377 | 1.0134 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 22.39 | 27.76 | 26 | 1305 | 0.0199 | -0.0117 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 22.39 | 27.76 | 1384 | 1305 | 1.0600 | 1.0211 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.09 | 27.76 | 1048 | 1461 | 0.7170 | 0.8870 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.09 | 27.76 | 1430 | 1461 | 0.9784 | 0.9924 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.09 | 27.76 | 28 | 1461 | 0.0192 | 0.0015 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 24.09 | 27.76 | 1300 | 1461 | 0.8894 | 0.9594 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 25.79 | 27.76 | 1190 | 1605 | 0.7414 | 0.9003 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 25.79 | 27.76 | 1322 | 1605 | 0.8236 | 0.9348 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 25.79 | 27.76 | 22 | 1605 | 0.0137 | -0.0389 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 25.79 | 27.76 | 1331 | 1605 | 0.8292 | 0.9370 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 27.49 | 27.76 | 1317 | 1723 | 0.7643 | 0.9118 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 27.49 | 27.76 | 1406 | 1723 | 0.8160 | 0.9329 | MN20160318_Q01 | I11 |